Dramatic twists and turns in the top ten. This is becoming a scary stock picker environment. There were three major winners and the rest lost ground - some serious ground.
In the week of Moderna's Phase III announcement, it went from a return of 245% to 276%, remaining in third place overall. The biggest gainer was Sorrento which went from a 197% return to 248%. This is one of the most volatile of all the COVID VACCINE STOCKS.
Translate Bio went from a return of 111% up to 142% to return to the TOP TEN for the first time since June 28. It's one of the few of these stocks that have moved from the bottom ten to the top ten.
The top two, Novavx and Arcturus, along with OncoSec (4th) had the worst weeks, with their respective returns moved down over 50%.
No comments:
Post a Comment